FindTrial
Sign In

pancreatic surgical procedure

PROCEDURE2 trials

Sponsors

University of Washington, Emory University

Conditions

Adenocarcinoma of the PancreasBorderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8Stage IA Pancreatic CancerStage IB Pancreatic CancerStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer

Phase 2

Perioperative Therapy for Resectable Pancreatic Cancer
CompletedNCT00609336
University of WashingtonAdenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer +2
Start: 2008-01-31End: 2016-12-31Updated: 2017-07-13
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
RecruitingNCT06423326
Emory UniversityBorderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 +2
Start: 2024-08-06End: 2027-12-31Target: 36Updated: 2026-04-22

Related Papers

Updated results of a single-arm phase II clinical trial of gemcitabine, cisplatin, and nab-paclitaxel as neoadjuvant therapy for pancreatic ductal adenocarcinoma.
Journal of Clinical Oncology2026-05-28
A phase II study of perioperative therapy for patients with resectable and borderline-resectable pancreatic adenocarcinoma.
Journal of Clinical Oncology2014-05-204 citations